StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Somil Mehta, Sharekhan

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

bySomil Mehta, SharekhanHorizon: NA (inferred Swing (≤2wk))29 Jun 2026via CNBC Awaaz.

Entry₹1,893Inferred
Target₹1,950
Total upside +3.01% (call closed)
Stop loss₹1,855-2.01% risk
Exit₹1,9509 Jul 2026, 10:25 am
Target hit+3.01%0.00%upside left
Follow Somil Mehta for new calls(21% target hit, 253 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 9:33 pm IST
4 supporting0 opposing
Supports the BUY call (4)

1 advisor has an active intraday BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·9 Jul · today

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·9 Jul · today

Sun Pharma to acquire Innovcare Lifesciences for ₹271.2 crore

NewsGoogle News·21 Jun · 3w ago

(opens in new tab)

Sun Pharma has entered into an agreement to acquire 100% outstanding shares of Innovcare Lifesciences Private Limited for approximately Rs 271.2 Crores. Innovcare is engaged in marketing, distribution

BSE · Company Update·20 Jun · 3w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Somil Mehta, Sharekhan

Every call and its outcome